NanoString Technologies Inc (NSTG):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NanoString Technologies Inc (NSTG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8018
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company’s products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and pathways, among others. Its nCounter MAX analysis system provides cost-effective method to profile various miRNA, miRGE or DNA molecules simultaneously employing a novel digital molecular barcoding technology. The company sells its products through direct sales force and distributors in Austria, Poland, Czech Republic, Slovakia, Hungary, Croatia, Slovenia, Bosnia Herzegovina, Serbia, Romania, Albania, Macedonia and Bulgaria, among others. NanoString is headquartered in Seattle, Washington, the US.

NanoString Technologies Inc (NSTG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NanoString Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
NanoString Technologies Raises US$0.2 Million In Venture Financing 12
NanoString Technologies Raises US$15 Million In Series E Financing 13
NanoString Technologies To Raise US$0.65 Million In Venture Financing 15
Partnerships 16
NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 16
NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 17
NanoString Enters into Co-Development Agreement with Celgene 18
NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 19
Licensing Agreements 20
NanoString Technologies Enters Into Option For Licensing Agreement With Massachusetts General Hospital 20
Equity Offering 21
NanoString Technologies Completes Underwriters Exercise of Over-Allotment Option of Public offering of Shares of Shares for USD57.5 Million 21
NanoString Technologies Plans to Raise up to USD40 Million in Private Placement of Shares 23
NanoString Technologies Completes Public Offering Of Shares For US$55 Million 24
NanoString Technologies Completes IPO Of Shares For US$54 Million 26
NanoString Technologies Inc – Key Competitors 28
NanoString Technologies Inc – Key Employees 29
NanoString Technologies Inc – Locations And Subsidiaries 30
Head Office 30
Recent Developments 31
Financial Announcements 31
Aug 07, 2018: NanoString Technologies Releases Operating Results for Second Quarter of 2018 31
Jul 16, 2018: NanoString Technologies Provides Preliminary Revenue Results for Second Quarter 2018 33
May 08, 2018: NanoString Technologies Releases Operating Results for First Quarter of 2018 34
Jan 08, 2018: NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017 36
Nov 02, 2017: NanoString Technologies Releases Operating Results for Third Quarter of 2017 37
Oct 11, 2017: NanoString Announces Preliminary Revenue for Third Quarter of Fiscal Year 2017 38
Aug 08, 2017: NanoString Technologies Releases Operating Results for Second Quarter of 2017 39
May 04, 2017: NanoString Technologies Releases Operating Results for First Quarter of 2017 40
Mar 01, 2017: NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook 41
Jan 10, 2017: NanoString Technologies Provides Preliminary Operational and Financial Results for 2016 42
Corporate Communications 43
May 10, 2017: NanoString Appoints Elisha W. Finney to Board of Directors 43
Product News 44
Apr 03, 2017: Digital Spatial Profiling Technology Enables Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Immune Response to Tumors 44
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NanoString Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NanoString Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 9
NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
NanoString Technologies Raises US$0.2 Million In Venture Financing 12
NanoString Technologies Raises US$15 Million In Series E Financing 13
NanoString Technologies To Raise US$0.65 Million In Venture Financing 15
NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 16
NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 17
NanoString Enters into Co-Development Agreement with Celgene 18
NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 19
NanoString Technologies Enters Into Option For Licensing Agreement With Massachusetts General Hospital 20
NanoString Technologies Completes Underwriters Exercise of Over-Allotment Option of Public offering of Shares of Shares for USD57.5 Million 21
NanoString Technologies Plans to Raise up to USD40 Million in Private Placement of Shares 23
NanoString Technologies Completes Public Offering Of Shares For US$55 Million 24
NanoString Technologies Completes IPO Of Shares For US$54 Million 26
NanoString Technologies Inc, Key Competitors 28
NanoString Technologies Inc, Key Employees 29

List of Figures
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NanoString Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
NanoString Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[NanoString Technologies Inc (NSTG):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Paramount Resources Ltd (POU):企業の財務・戦略的SWOT分析
    Summary Paramount Resources Ltd (Paramount Resources) is an energy company that offers exploration, production, development, and marketing of oil and gas products. The company offers products such s crude oil, fuel oil, natural gas and natural gas liquids. It operates in three segments such as princ …
  • Host Hotels & Resorts, Inc.:企業の戦略・SWOT・財務情報
    Host Hotels & Resorts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Host Hotels & Resorts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Marquee Energy Ltd (MQX):石油・ガス:M&Aディール及び事業提携情報
    Summary Marquee Energy Ltd (Marquee), formerly known as Alberta Oilsands Inc, is an upstream energy company that explores and produces oil, natural gas, and natural gas liquids from its assets in Michichi, Alberta. The company’s Michichi assets are in Michichi, Drumheller, Watts, Wildunn Creek, Deli …
  • ConSynance Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary ConSynance Therapeutics Inc (ConSynance Therapeutics) is a drug discovery company that concentrates on the development of new therapeutic solutions for unmet medical needs. The company’s pipeline programs include CSTI-100, CSTI-200, and CSTI-300 among others. It develops pipeline programs fo …
  • Foundation Medicine Inc (FMI)-製薬・医療分野:企業M&A・提携分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for soli …
  • Victorian WorkCover Authority:企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • OBI Pharma Inc (4174):企業の財務・戦略的SWOT分析
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • Viridian Energy Supply Ltd.:電力:M&Aディール及び事業提携情報
    Summary Viridian Energy Supply Ltd. (trading as Energia) a subsidiary of Viridian Group Investments Limited, is a vertically integrated energy company that supplies electricity and gas; and provides energy efficiency services. It provides energy to micro, small and medium-sized enterprises, and resi …
  • Transnet SOC Ltd:企業の戦略的SWOT分析
    Transnet SOC Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Taiga Biotechnologies Inc-製薬・医療分野:企業M&A・提携分析
    Summary Taiga Biotechnologies Inc (Taiga Biotech) is a biopharmaceutical company that develops protein and cellular therapies. The company develops therapies for diseases including cancers and infectious diseases. Its pipeline products include programs such as stem cell therapy and target specific T …
  • ProMIS Neurosciences Inc (PMN):企業の製品パイプライン分析
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of neurodegenerative disorders. Its major products include tests functional assa …
  • Aramex (ARMX):企業の財務・戦略的SWOT分析
    Summary Aramex, formerly Arab International Logistics (Aramex) Co PJSC is a transport and logistics service provider that offers supply chain solutions. The company offers solutions such as e-commerce, logistics, small business solutions, developers solutions center, drop and ship, shop and ship, am …
  • Primeline Energy Holdings Inc (PEH):企業の財務・戦略的SWOT分析
    Summary Primeline Energy Holdings Inc (Primeline Energy) is an upstream company that explores oil and gas. The company acquires and explores crude oil and natural gas properties across China. It owns and operates exploration and development rights in two offshore blocks in the East China Sea. Primel …
  • Amcor Limited:企業の戦略・SWOT・財務情報
    Amcor Limited - Strategy, SWOT and Corporate Finance Report Summary Amcor Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Allscripts Healthcare Solutions Inc (MDRX):企業の財務・戦略的SWOT分析
    Allscripts Healthcare Solutions Inc (MDRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Peregrine Holdings Ltd:企業の戦略・SWOT・財務分析
    Peregrine Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Peregrine Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • HDFC Standard Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    HDFC Standard Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary HDFC Standard Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Texas Instruments Incorporated (TXN):電力:M&Aディール及び事業提携情報
    Summary Texas Instruments Incorporated (TI) designs and manufactures and sells semiconductors to electronics designers and manufacturers the world over. It offers catalog and application-specific standard semiconductor products through its analog chips and embedded processors divisions. Its analog c …
  • Amec Foster Wheeler plc (formerly AMEC plc):戦略・SWOT・企業財務分析
    Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report Summary Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • CEZ, a. s.:企業の戦略・SWOT・財務分析
    CEZ, a. s. - Strategy, SWOT and Corporate Finance Report Summary CEZ, a. s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆